Hypertension and cerebrovascular damage

Atherosclerosis

Volumn 205, Issue 2, 2009, Pages 331-341

  Veglio, Franco ^a   Paglieri, Cristina ^a   Rabbia, Franco ^a   Bisbocci, Daniela ^a   Bergui, Mauro ^a   Cerrato, Paolo ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Arterial hypertension; Cognitive decline; Large vessel disease; Small vessel disease

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; THIAZIDE DIURETIC AGENT;

ATHEROSCLEROSIS; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; HYPERTENSION ENCEPHALOPATHY; NEUROIMAGING; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SECONDARY PREVENTION; STROKE; TRANSIENT ISCHEMIC ATTACK; WHITE MATTER;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRAIN; CEREBRAL HEMORRHAGE; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; HYPERTENSION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; STROKE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67650896298     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.10.028     Document Type: Review

References (121)

1. Aronow W.S., and Frishman W.H. Treatment of hypertension and prevention of ischemic stroke. Curr Cardiol Rep 6 2 (2004) 124-129
2. Van der Flier W, van Straaten E, Barkhof F, et al., on behalf of the LADIS Study Group. Small vessel disease and general cognitive function in non-disabled elderly: the LADIS study. Stroke 2005; 36:2116-20.
3. Forette F., Seux M.L., Staessen J., et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352 (1998) 1347-1351
4. Forette F., et al. The prevention of dementia with antihypertensive treatment. New evidence from the Systolic Hypertension in Europe (Syst-Eur) Study. Arch Intern Med 162 (2002) 2046-2052
5. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P., and He J. Global burden of hypertension: analysis of worldwide data. Lancet 365 (2005) 217-223
6. Ferri C.P., et al. Global prevalence of dementia: a Delphi consensus study. Lancet 366 (2005) 2112-2117
7. Beaglehole R., Irwin A., and Prentice T. The World Health Report 2003-Shaping the future (2003), World Health Organization, Geneva, Switzerland
8. Cerrato P., Grasso M., Imperiale D., et al. Stroke in young patients: etiopathogenesis and risk factors in different age classes. Cerebrovasc Dis 18 2 (2004) 154-159
9. Staessen J.A., Richard T., and Birkenhager W.H. Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. Hypertension 49 (2007) 389-400
10. Realdi A., Mascagna V., Ciccariello L., et al. Impaired cerebral vasoreactivity in hypertensives: an early marker of vascular dementia?. J Hypertens 21 Suppl 4 (2003) S166
11. Schwartz R.B. Hyperperfusione encephalopathies: hypertensive encephalopathy and related conditions. The Neurologist vol. B 1 (2002) 22-34
12. Oliveira-Filho J., and Koroshetz W.J. Magnetic resonance imaging in acute stroke: clinical perspective. Top Magn Reson Imaging 11 5 (2000) 246-258
13. Bergui M., and Bradac G.B. DWI as a marker for focal cerebral ischaemia. Lancet Neurol 5 6 (2006) 470-471
14. Zampaglione B., Pascale C., Marchisio M., and Cavallo-Perin P. Hyertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension 27 (1996) 144-147
15. Rosenblum W.I. The importance of fibrinoid necrosis as the cause of cerebral hemorrhage in hypertension. Commentary. J Neuropathol Exp Neurol 52 (1993) 11-13
16. Schaefer P.W., Buonanno F.S., Gonzalez R.G., and Schwamm L.H. Diffusion-weighted imaging discriminates between cytotoxic and vasogenic oedema in a patient with eclampsia. Stroke 28 5 (1997) 1082-1085
17. Bakker R.C., Verburgh C.A., van Buchem M.A., and Paul L.C. Hypertension, cerebral oedema and fundoscopy. Nephrol Dial Transplant 18 11 (2003) 2424-2427
18. Neuwelt E.A. Mechanism of disease: the blood-brain barrier. Neurosurgery 54 (2004) 131-142
19. Coutts S.B., Hill M.D., and Hu W.Y. Hyperperfusion syndrome. Neurosurgery 53 (2003) 1053-1060
20. Kumai Y., Toyoda K., Fujii K., and Ibayashi S. Hypertensive encephalopathy extending into the whole brainstem and deep structures. Hypertens Res 25 5 (2002) 797-800
21. Port J.D., and Beauchamp Jr. N.J. Reversible intracerebral pathologic entities mediated by vascular autoregulatory dysfunction. Radiographics 18 (1998) 353-367
22. Covarrubias D.J., Luetmer P.H., and Campeau N.G. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. Am J Neuroradiol 23 6 (2002) 1038-1048
23. Adams Jr. H.P., Bendixen B.H., Kappelle L.J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24 1 (1993) 35-41
24. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
25. Moossy J. Pathology of cerebral atherosclerosis. Influence of age, race, and gender. Stroke 24 Suppl (1993) 122-123
26. Rovira A., Grive E., Rovira A., and Alvarez-Sabin J. Distribution territories and causative mechanisms of ischemic stroke. Eur Radiol 15 March (3) (2005) 416-426
27. Rosenblum W.I. Miliary aneurisms and "fibrinoid" degeneration of cerebral blood vessels. Hum Pathol 8 (1997) 133-139
28. Van Swieten J.C., Van Den Hout J.H., Van ketel B.A., et al. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly: a morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain 114 (1991) 761-774
29. Van Swieten J.C., Geyskes G.G., Derix M.M., et al. Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol 30 (1991) 825-830
30. Boiten J., Lodder J., and Kessels F. Two clinically distinct lacunar infarct entities? A hypothesis. Stroke 24 (1993) 652-656
31. Lammie G.A., Brannan F., Slattery J., and Warlow C. Nonhypertesive cerebral small-vessel disease: an autopsy study. Stroke 28 (1997) 2222-2229
32. Fisher C.M. Lacunar infarcts: a review. Cerebrovasc Dis 1 (1991) 311-320
33. Weisberg L.A. Diagnostic classification of stroke, especially lacunes. Stroke 19 9 (1998) 1071-1073
34. Bamford J.M., and Warlow C.P. Evolution and testing of the lacunar hypothesis. Stroke 19 9 (1988) 1074-1081
35. Horowitz D.R., Tuhrim S., Weinberger J.M., and Rudolph S.H. Mechanism in lacunar infarction. Stroke 23 (1992) 325-327
36. Dozono K., Ishii N., Nishihara Y., and Horie A. An autopsy study of the incidence of lacunes in relation to age, hypertension and arteriosclerosis. Stroke 22 (1991) 993-996
37. Melo T.P., Bogousslavsky J., van Melle G., and Regli F. Pure motor stroke: a reappraisal. Neurology 42 (1992) 789-795
38. Kim J.S. Pure sensory stroke: clinical-radiological correlates in 21 cases. Stroke 23 (1992) 983-987
39. Moulin T. Ataxic hemiparesis: 100 vascular cases. Cerebrovasc Dis 2 (1992) 199 [Abstract]
40. Glass J.D., Levey A.I., and Rothstein J.D. The dysarthria-clumsy hand syndrome. A distinct clinical entity related to pontine infarction. Ann Neurol 27 (1990) 487-494
41. Kato H., Izumiyama M., Izumiyama K., Takahashi A., and Itoyama Y. Silent cerebral microbleeds on T2-weighted MRI: correlation with stroke subtype, stroke recurrence, and leukoaraiosis. Stroke 33 (2002) 1536-1540
42. Gorter J.W., and for the Stroke Prevention in Reversible Ischemia Trial (SPIRIT) and European Atrial Fibrillation Trial (EAFT) Study Groups. Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Neurology 53 (1999) 1319-1327
43. Smith E.E., Rosand J., Knudsen B.A., Hyleck E.M., and Greenberg S.M. Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke: the Cardiovascular Health Study. Neurology 59 (2002) 193-197
44. Kuo H.K., and Lipsitz L.A. Cerebral white matter changes and geriatric syndromes: is there a link?. J Gerontol A Biol Sci Med Sci 59 8 (2004) 818-826
45. Cadelo M., Inzitari D., Pracucci G., and Mascalchi M. Predictors of leukoaraiosis in elderly neurological patients. Cerebrovasc Dis 1 (1991) 345-351
46. Junqué C., Pujol J., Vendrell P., et al. Leuko-araiosis on magnetic resonance imaging and speed of mental processing. Arch Neurol 47 (1990) 151-156
47. Coffey C.E., Figiel G.S., Djang W.T., and Weiner R.D. Subcortical hyperintensity on magnetic resonance imaging: a comparison of normal and depressed elderly subjects. Am J Psychiatry 147 (1990) 187-189
48. Breitner J.C.S., Husain M.M., Figiel G.S., Krishnan K.R.R., and Boyko O.B. Cerebral white matter disease in late-onset paranoid psychosis. Biol Psychiatry 28 (1990) 266-274
49. Dupont R.M., Jernigan T.L., Butters N., et al. Subcortical abnormalities detected in bipolar affective disorder using magnetic resonance imaging. Arch Gen Psychiatry 47 (1990) 55-59
50. Swayze II V.W., Andreasen N.C., Alliger R.J., Ehrhardt J.C., and Yuh W.T.C. Structural brain abnormalities in bipolar affective disorder. Arch Gen Psychiatry 47 (1990) 1054-1059
51. Gass A., Ay H., Szabo K., and Koroshetz W.J. Diffusion-weighted MRI for the "small stuff": the details of acute cerebral ischaemia. Lancet Neurol 3 1 (2004) 39-45
52. Lee S.H., Kwon S.J., Kim K.S., Yoon B.W., and Roh J.K. Cerebral microbleeds in patients with hypertensive stroke. Topographical distribution in the supratentorial area. J Neurol 251 10 (2004) 1183-1189
53. Pantoni L., and Garcia J.H. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. Stroke 26 7 (1995) 1293-1301
54. Pantoni L., and Garcia J.H. Pathogenesis of leukoaraiosis: a review. Stroke 28 (1997) 652-659
55. Shimode K., Kobayashi S., Imaoka K., Umegae N., and Nagai A. Leukoencephalopathy-related cerebral amyloid angiopathy with cystatin C deposition. Stroke 27 8 (1996) 1417-1419
56. Caulo M., Tampieri D., Brassard R., Christine Guiot M., and Melanson D. Cerebral amyloid angiopathy presenting as nonhemorrhagic diffuse encephalopathy: neuropathologic and neuroradiologic manifestations in one case. Am J Neuroradiol 22 6 (2001) 1072-1076
57. Tournier-Lasserve E., Joutel A., Melki J., et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet 3 3 (1993) 256-259
58. LaPoint S.F., Patel U., and Rubio A. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Adv Anat Pathol 7 5 (2000) 307-321
59. Miyao S., Takano A., Teramoto J., and Takahashi A. Leukoaraiosis in relation to prognosis for patients with lacunar infarction. Stroke 23 (1992) 1434-1438
60. Inzitari D., Di Carlo A., Mascalchi M., Pracucci G., and Amaducci L. The cardiovascular outcome of patients with motor impairment and extensive leukoaraiosis. Arch Neurol 52 (1995) 687-691
61. Yamauchi H., Fukuda H., and Oyanagi C. Significance of white matter high intensity lesions as a predictor of stroke from arteriolosclerosis. J Neurol Neurosurg Psychiatry 72 (2002) 576-582
62. Giele J.L., Witkamp T.D., Mali W.P., van der Graaf Y., and SMART Study Group. Silent brain infarcts in patients with manifest vascular disease. Stroke 35 March (3) (2004) 742-746
63. Lexa F.J., Trojanawski J.Q., and Braffman B.H. The aging brain and neurodegenerative disease. In: Atlas S.W. (Ed). Magnetic resonance imaging of the brain and spine. 2nd ed. (1996), Lippincott-Raven, Philadelphia, PA 803-870
64. Song C.J., Kim J.H., Kier E.L., and Bronen R.A. MR imaging and histologic features of subinsular bright spots on T2-weighted MR images: Virchow-Robin spaces of the extreme capsule and insular cortex. Radiology 214 (2000) 671-677
65. Qureshi A.I., Tuhrim S., Broderick J.P., Batjer H.H., Hondo H., and Hanley D.F. Spontaneous intracerebral hemorrhage. N Engl J Med 344 May (19) (2001) 1450-1460
66. Thrift A.G., McNeil J.J., Forbes A., and Donnan G.A. Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage. Hypertension 31 (1998) 1223-1229
67. Qureshi A.I., Suri M.A.K., Safdar K., Ottenlips J.R., Janssen R.S., and Frankel M.R. Intracerebral hemorrhage in blacks: risk factors, subtypes, and outcome. Stroke 28 (1997) 961-964
68. Massaro A.R., Sacco L.R., Mohr J.P., Foulkes M.A., Tatemichi T.K., and Price T.R. Clinical discriminators of lobar and deep hemorrhage: The Stroke Data Bank. Neurology 41 (1991) 1881-1885
69. Heiskanen O. Treatment of spontaneous intracerebral and intracerebellar hemorrhages. Stroke 24 Suppl I (1993) I94-I95
70. Mayer S.A., Sacco R.L., Shi T., and Mohr J.P. Neurologic deterioration in noncomatose patient with supra-tentorial intracerebral hemorrhage. Neurology 44 (1994) 1379-1384
71. Kase C.S., Mohr J.P., and Caplan L.R. Intracerebral hemorrhage. In: Barnett H.J.M., Mohr J.P., Stein B.M., and Yatsu F.M. (Eds). Stroke: pathophysiology, diagnosis, and management. 2nd ed. (1992), Churchill Livingston, New York 561-616
72. Wakai S., Kumakura N., and Nagai M. Lobar intracerebral hemorrhage. A clinical, radiographic and pathological study of 29 consecutive operated cases with negative angiography. J Neurosurg 76 (1992) 231-238
73. Challa V.R., Moody D.M., and Bell M.A. The Charcot-Bouchard aneurysms controversy: impact of a new histologic technique. J Neuropathol Exp Neurol 51 (1992) 264-271
74. Spangler K.M., Challa V.R., Moody, and Bell M.A. Arteriolar tortuosity of the white matter in aging and hypertension. A microradiographic study. J Neuropathol Exp Neurol 53 (1994) 22-26
75. Kreel L., Kay R., Woo J., Wong H.Y., and Nicholls M.G. The radiological (CT) and clinical sequelae of primary intracerebral hemorrhage. Br J Radiol 64 (1991) 1096-1100
76. McCarron M.O., and Nicoll J.A. Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage. Lancet Neurol 3 8 (2004) 484-492
77. Nabavi D.G., Csiba L., and Ringelstein E.B. Role of cerebral amyloid angiopathy in intracerebral hemorrhage in hypertensive patients. Neurology 64 7 (2005) 1233-1237
78. Dickinson C.J. Why are strokes related to hypertension? Classic studies and hypotheses revisited. J Hypertens 19 (2001) 1515-1521
79. Faraci F.M., Baumbach G.L., and Heistad D.D. Cerebral circulation: humoral regulation and effects of chronic hypertension. J Am Soc Nephrol 1 (1990) 53-57
80. de la Torre J.C. Hemodynamics of deformed microvessels in Alzheimer's disease brain. Ann NY Acad Sci 826 (1997) 75-91
81. Iadecola C. Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5 (2004) 347-360
82. Escobales N., and Crespo M.J. Oxidative-nitrosative stress in hypertension. Curr Vasc Pharmacol 3 (2005) 231-246
83. Faraci F.M. Oxidative stress: the curse that underlies cerebral vascular dysfunction?. Stroke 36 (2005) 186-188
84. Fisk J.D., Merry H.R., and Rockwood K. Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology 61 (2003) 1179-1184
85. Fratiglioni L., De Ronchi D., and Agùero-Torres H. World-wide prevalence and incidence of dementia. Drugs Aging 15 (1999) 365-375
86. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., and He J. Global burden of hypertension: analysis of worldwide data. Lancet 365 (2005) 217-223
87. Fratiglioni L., Launer L., and Andersen K. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 54 Suppl 5 (2000) S10-S15
88. Launer L.J. Demonstrating the case that AD is a vascular disease: epidemiologic evidence. Ageing Res Rev 1 (2002) 61-77
89. de la Torre J.C. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma and dialectics. Lancet Neurol 3 (2004) 184-190
90. Launer L.J., Masaki K., Petrovich H., Foley D., and Havlik R.J. The association between blood pressure levels and late-life cognitive function: the Honolulu-Asia Aging Study. JAMA 274 (1995) 1846-1851
91. Amenta F., Mignini F., Rabbia F., Tomassoni D., and Veglio F. Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: Analysis of published clinical data. J Neurol Sci 203/204 (2002) 147-151
92. Franklin S.S., Gustin I.V.W., and Wong N.D. Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation 96 (1997) 308-315
93. Bots M.L., Witteman J.C.M., Hofman A., de Jong P.T., and Grobbee D.E. Low diastolic blood pressure and atherosclerosis in elderly subjects: the Rotterdam Study. Arch Intern Med 156 (1996) 843-848
94. Suter O.-C., Sunthorn T., and Kraftisik R. Cerebral hypoperfusion generates cortical watershed microinfasrcts in Alzheimer disease. Stroke 33 (2002) 1986-1992
95. Vagnucci A.H., and Li W.W. Alzheimer's disease and angiogenesis. Lancet 361 (2003) 605-608
96. Kalback W., Esh C., and Castano E.M. Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease. Neurol Res 26 (2004) 525-539
97. van Dijk E.J., Breteler M.M., and Schmidt R. The association between blood pressure, hypertension, and cerebral white matter lesions: the Cardiovascular Determinants of Dementia Study. Hypertension 44 (2004) 625-630
98. Schmidt R., Petrovic K., Ropele S., Enzinger C., and Fazekas F. Progression of leukoaraiosis and cognition. Stroke 38 9 (2007) 2619-2625
99. Chui H., Victiroff J., Margolin D., Jagust W., Shankle R., and Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's disease diagnostic and treatment centres. Neurology 42 (1992) 473-480
100. Roman G., Tatemichi T., Erkinjuntti T., et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International workshop. Neurology 43 (1993) 250-260
101. Gunning-Dixon F., and Raz N. The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology 14 (2000) 224-232
102. Hachinski V., Iadecola C., Petersen R., et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 37 (2006) 2220-2241
103. Desmond D. Cognition and white matter lesions. Cerebrovasc Dis 13 Suppl 2 (2002) 53-57
104. Parneti L., Senin U., and Mecocci P. Cognitive enhancement therapy for Alzheimer's disease: the way forward. Drugs 53 (1997) 752-768
105. Mason R.P., Leeds P.R., and Jacob R.F. Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells. J Neurochem 72 (1999) 1448-1456
106. Farkas E., De Jong G.I., and Apro E. Calcium antagonists decrease capillary wall damage in aging hypertensive rat brain. Neurobiol Aging 22 (2001) 299-309
107. Morich F.J., Bieber F., and Lewis J.M. Nimodipine in the treatment of probable Alzheimer's disease: result of two multicentre trials. Clin Drug Invest 11 (1996) 185-195
108. Amenta F., Strocchi P., and Sabbatini M. Vascular and neuronal hypertensive brain damage: protective effect of treatment with nicardipine. J Hypertens 14 Suppl 3 (1996) S29-S36
109. Schrader J., et al. Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention. Principal Results of a Prospective Randomized Controlled Study (MOSES). Stroke 36 (2005) 1218-1226
110. Fournier A., Messerli F., Achard J., and Fernandez L. Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent randomised clinical trials. J Am Coll Cardiol 43 (2004) 1343-1347
111. Iadecola C., and Gorelick P.B. Hypertension, angiotensin, and stroke: beyond blood pressure. Stroke 35 (2004) 348-350
112. Watanabe T., Barker T.A., and Berk B.C. Angiotensin II and the endothalium: diverse signals and effects. Hypertension 45 (2005) 163-169
113. Jandeleit-Dahm K.A., Tikellis C., Reid C.M., Johnston C.I., and Cooper M.E. Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes?. J Hypertens 23 (2005) 463-473
114. Wachtell K., Lehto M., Gerdts E., et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 45 (2005) 712-719
115. Applegate W.B., Pressels S., Wittes J., et al. Impact of the treatment of isolated systolic hypertension on behavioural variables: results from the Systolic Hypertension in the Elderly Program. Arch Intern Med 154 (1994) 2154-2160
116. Prince M., Bird A.S., Blizard R.A., and Mann A.H. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults. Br Med J 312 (1996) 801-805
117. Forette F., Seux M.L., Staessen J.A., et al. Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352 (1998) 2046-2052
118. Forette F., Seux M.L., Staessen J.A., et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Systolic Hypertension in Europe Investigators. Arch Intern Med 162 (2002) 2046-2052
119. Tzourio C., Anderson C., Chapman N., et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 163 (2003) 1069-1075
120. Lithell H., Hansson L., Skoog I., et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 21 (2003) 875-886
121. Qureshi A.I., Tuhrim S., Broderick J.P., Batjer H.H., Hondo H., and Hanley D.F. Spontaneous intracerebral hemorrhage. N Engl J Med. 344 May (19) (2001) 1450-1460